Search

Displaying results 21 - 30 of 31461 in total
  1. Drug

    Omidubicel

    go.drugbank.com/drugs/DB17132
    ApprovedInvestigational

    Umbilical blood cord cells are expanded _ex-vivo_ and [nicotinamide] (a form of vitamin B3) is used as an active agent in the culture system to inhibit the differentiation and increase the functionality … It is administered as a single intravenous dose specific to each patient.

    Synonyms: Allogeneic, ex-vivo expanded, umbilical cord blood-derived hematopoietic CD34+ progenitor cells - cultured fraction (CF)
  2. Drug

    Yttrium Y-90 Labetuzumab

    go.drugbank.com/drugs/DB17987
    Experimental

    Synonyms: Yttrium y 90 labetuzumab
  3. Drug

    Edotreotide yttrium Y-90

    go.drugbank.com/drugs/DB17160
    Investigational

    Synonyms: Y-90 dota-tyr(3)-octreotide, Dotatoc yttrium Y-90
  4. Drug

    Yttrium Y-90 epratuzumab tetraxetan

    go.drugbank.com/drugs/DB18801
    Investigational

    Synonyms: Epratuzumab tetraxetan yttrium Y-90, Yttrium y 90 epratuzumab tetraxetan
  5. Drug

    Yttrium y 90 capromab pendetide

    go.drugbank.com/drugs/DB33697
    Experimental

    Synonyms: Yttrium y 90 capromab pendetide
  6. Drug

    Anti-tac 90 y-hat

    go.drugbank.com/drugs/DB33716
    Experimental

    Synonyms: Anti-tac 90 y-hat
  7. Drug

    Yttrium Y-90 clivatuzumab tetraxetan

    go.drugbank.com/drugs/DB15368
    Investigational

    Yttrium Y-90 clivatuzumab tetraxetan is under investigation in clinical trial NCT00603863 (Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer).

    Synonyms: Yttrium y 90 clivatuzumab tetraxetan, Yttrium Y-90 clivatuzumab tetraxetan
  8. Drug

    Tabituximab barzuxetan yttrium Y-90

    go.drugbank.com/drugs/DB17982
    Experimental

    A version of [tabituximab barzuxetan] radiolabeled with yttrium-90.

  9. Drug

    Glyceryl 1-oleate

    go.drugbank.com/drugs/DB13171
    Experimental

    Synonyms: MG (18:1/0:0/0:0), 1-monoolein
  10. Drug

    Marnetegragene autotemcel

    go.drugbank.com/drugs/DB17595
    Approved

    Severe leukocyte adhesion deficiency-I (LAD-I) is a genetic disorder leading to frequent life-threatening infections and high fatality risks among affected pediatric patients. … [L56116, A275467] Allogeneic hematopoietic stem cell transplant is a curative option but is limited by issues such as donor availability, a high incidence of graft-versus-host disease, and graft failure

    Synonyms: Autologous CD34+ cells transduced ex vivo with a lentiviral vector (Chim-CD18-WPRE) encoding the ITGB2 gene, Hematopoietic stem cells modified with a lentiviral vector containing the CD18 (integrin beta 2) gene